Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
- NCIt
- C8561
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Genomics
28 cohorts mapped to this entity or its descendants. Each frequency is affected / profiled within one cohort; cohorts are shown separately because case selection, sequencing depth and definitions differ. By default the cohort with the most cases profiled is shown.
60 cases with simple somatic mutation data · 63 cases total · Data Release 46.0 · mapped to Malignant Prostate Neoplasm CURATED_BROADER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|
Cohorts mapped to a descendant (e.g. a subtype) are included because their cases belong to this entity by definition; the mapping and its match type are shown per cohort.
| 1 | TP53 | Ssm | 17 | 60 | 28.3% | gdc |
| 2 | RIMS2 | Ssm | 9 | 60 | 15% | gdc |
| 3 | SPOP | Ssm | 8 | 60 | 13.3% | gdc |
| 4 | FOXA1 | Ssm | 8 | 60 | 13.3% | gdc |
| 5 | TTN | Ssm | 7 | 60 | 11.7% | gdc |
| 8 | HMCN1 | Ssm | 5 | 60 | 8.3% | gdc |
| 10 | FAM161A | Ssm | 5 | 60 | 8.3% | gdc |
| 7 | PTEN | Ssm | 5 | 60 | 8.3% | gdc |
| 9 | XPO5 | Ssm | 5 | 60 | 8.3% | gdc |
| 6 | XIAP | Ssm | 5 | 60 | 8.3% | gdc |
| 14 | TYK2 | Ssm | 4 | 60 | 6.7% | gdc |
| 20 | OBSCN | Ssm | 4 | 60 | 6.7% | gdc |
| 16 | DCHS2 | Ssm | 4 | 60 | 6.7% | gdc |
| 15 | MUC4 | Ssm | 4 | 60 | 6.7% | gdc |
| 17 | MUC16 | Ssm | 4 | 60 | 6.7% | gdc |
| 18 | KMT2D | Ssm | 4 | 60 | 6.7% | gdc |
| 19 | MGA | Ssm | 4 | 60 | 6.7% | gdc |
| 21 | NOTCH1 | Ssm | 4 | 60 | 6.7% | gdc |
| 11 | SDK1 | Ssm | 4 | 60 | 6.7% | gdc |
| 12 | DNAH17 | Ssm | 4 | 60 | 6.7% | gdc |
| 13 | DNAH3 | Ssm | 4 | 60 | 6.7% | gdc |
| 42 | KNDC1 | Ssm | 3 | 60 | 5% | gdc |
| 43 | DEAF1 | Ssm | 3 | 60 | 5% | gdc |
| 44 | TNN | Ssm | 3 | 60 | 5% | gdc |
| 45 | SLC12A7 | Ssm | 3 | 60 | 5% | gdc |
| 46 | MAP4K1 | Ssm | 3 | 60 | 5% | gdc |
| 48 | CACNA1A | Ssm | 3 | 60 | 5% | gdc |
| 49 | MATR3 | Ssm | 3 | 60 | 5% | gdc |
| 50 | RELN | Ssm | 3 | 60 | 5% | gdc |
| 51 | SMC3 | Ssm | 3 | 60 | 5% | gdc |
Data updated 23 days agoSource updated Data Release 46.0
424 cases with simple somatic mutation data · 424 cases total · 2026-04-07 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 129 | 424 | 30.4% | cbioportal |
| 2 | SPOP | Ssm | 53 | 424 | 12.5% | cbioportal |
| 3 | FOXA1 | Ssm | 50 | 424 | 11.8% | cbioportal |
| 4 | PTEN | Ssm | 46 | 424 | 10.8% | cbioportal |
| 5 | APC | Ssm | 36 | 424 | 8.5% | cbioportal |
| 6 | KMT2C | Ssm | 34 | 424 | 8% | cbioportal |
| 7 | KMT2D | Ssm | 30 | 424 | 7.1% | cbioportal |
| 8 | ZFHX3 | Ssm | 25 | 387 | 6.5% | cbioportal |
| 10 | CDK12 | Ssm | 24 | 424 | 5.7% | cbioportal |
| 11 | PIK3CA | Ssm | 24 | 424 | 5.7% | cbioportal |
| 9 | ATM | Ssm | 24 | 424 | 5.7% | cbioportal |
| 12 | CTNNB1 | Ssm | 23 | 424 | 5.4% | cbioportal |
| 13 | BRCA2 | Ssm | 19 | 424 | 4.5% | cbioportal |
| 15 | MGA | Ssm | 14 | 387 | 3.6% | cbioportal |
| 14 | SPEN | Ssm | 15 | 424 | 3.5% | cbioportal |
| 16 | NCOR1 | Ssm | 13 | 424 | 3.1% | cbioportal |
| 57 | TP53BP1 | Ssm | 7 | 233 | 3% | cbioportal |
| 18 | CREBBP | Ssm | 12 | 424 | 2.8% | cbioportal |
| 17 | BRAF | Ssm | 12 | 424 | 2.8% | cbioportal |
| 19 | JAK1 | Ssm | 12 | 424 | 2.8% | cbioportal |
| 21 | GRIN2A | Ssm | 11 | 424 | 2.6% | cbioportal |
| 22 | PTPRT | Ssm | 11 | 424 | 2.6% | cbioportal |
| 20 | FAT1 | Ssm | 11 | 424 | 2.6% | cbioportal |
| 28 | NF1 | Ssm | 10 | 424 | 2.4% | cbioportal |
| 29 | NOTCH1 | Ssm | 10 | 424 | 2.4% | cbioportal |
| 27 | KMT2A | Ssm | 10 | 424 | 2.4% | cbioportal |
| 26 | ASXL2 | Ssm | 10 | 424 | 2.4% | cbioportal |
| 25 | ASXL1 | Ssm | 10 | 424 | 2.4% | cbioportal |
| 24 | ARID1B | Ssm | 10 | 424 | 2.4% | cbioportal |
| 23 | ARID1A | Ssm | 10 | 424 | 2.4% | cbioportal |
Data updated 22 days agoSource updated 2026-04-07
61 cases with simple somatic mutation data · 121 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 25 | 61 | 41% | cbioportal |
| 3 | ZFHX3 | Ssm | 8 | 61 | 13.1% | cbioportal |
| 2 | TTN | Ssm | 8 | 61 | 13.1% | cbioportal |
| 4 | ABCA13 | Ssm | 7 | 61 | 11.5% | cbioportal |
| 5 | RYR3 | Ssm | 7 | 61 | 11.5% | cbioportal |
| 7 | DNAH11 | Ssm | 6 | 61 | 9.8% | cbioportal |
| 6 | APC | Ssm | 6 | 61 | 9.8% | cbioportal |
| 8 | KMT2D | Ssm | 6 | 61 | 9.8% | cbioportal |
| 9 | MUC16 | Ssm | 6 | 61 | 9.8% | cbioportal |
| 10 | PTEN | Ssm | 6 | 61 | 9.8% | cbioportal |
| 11 | RB1 | Ssm | 6 | 61 | 9.8% | cbioportal |
| 14 | USH2A | Ssm | 5 | 61 | 8.2% | cbioportal |
| 12 | AR | Ssm | 5 | 61 | 8.2% | cbioportal |
| 13 | CSMD1 | Ssm | 5 | 61 | 8.2% | cbioportal |
| 20 | FAT4 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 25 | LPAR1 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 24 | JARID2 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 37 | ZNF646 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 30 | RYR1 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 29 | PLEC | Ssm | 4 | 61 | 6.6% | cbioportal |
| 28 | NEB | Ssm | 4 | 61 | 6.6% | cbioportal |
| 27 | NAALADL2 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 23 | HSPG2 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 22 | GRIA1 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 16 | ATM | Ssm | 4 | 61 | 6.6% | cbioportal |
| 17 | CDC42EP1 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 18 | COL6A3 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 19 | DGKB | Ssm | 4 | 61 | 6.6% | cbioportal |
| 21 | FREM2 | Ssm | 4 | 61 | 6.6% | cbioportal |
| 26 | MAGI3 | Ssm | 4 | 61 | 6.6% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
444 cases with simple somatic mutation data · 444 cases total · 2026-01-16 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 163 | 444 | 36.7% | cbioportal |
| 2 | TTN | Ssm | 88 | 444 | 19.8% | cbioportal |
| 3 | MUC16 | Ssm | 67 | 444 | 15.1% | cbioportal |
| 4 | AR | Ssm | 61 | 444 | 13.7% | cbioportal |
| 5 | SYNE1 | Ssm | 49 | 444 | 11% | cbioportal |
| 6 | CSMD3 | Ssm | 43 | 444 | 9.7% | cbioportal |
| 7 | FOXA1 | Ssm | 41 | 444 | 9.2% | cbioportal |
| 8 | KMT2C | Ssm | 40 | 444 | 9% | cbioportal |
| 9 | BRCA2 | Ssm | 37 | 444 | 8.3% | cbioportal |
| 10 | KMT2D | Ssm | 37 | 444 | 8.3% | cbioportal |
| 11 | AHNAK2 | Ssm | 35 | 444 | 7.9% | cbioportal |
| 12 | HMCN1 | Ssm | 32 | 444 | 7.2% | cbioportal |
| 13 | APC | Ssm | 31 | 444 | 7% | cbioportal |
| 14 | USH2A | Ssm | 31 | 444 | 7% | cbioportal |
| 16 | OBSCN | Ssm | 29 | 444 | 6.5% | cbioportal |
| 15 | CACNA1E | Ssm | 29 | 444 | 6.5% | cbioportal |
| 17 | LRP1B | Ssm | 28 | 444 | 6.3% | cbioportal |
| 19 | PTEN | Ssm | 28 | 444 | 6.3% | cbioportal |
| 20 | RYR1 | Ssm | 28 | 444 | 6.3% | cbioportal |
| 18 | PLEC | Ssm | 28 | 444 | 6.3% | cbioportal |
| 21 | ATM | Ssm | 27 | 444 | 6.1% | cbioportal |
| 23 | FAT3 | Ssm | 27 | 444 | 6.1% | cbioportal |
| 22 | DCHS2 | Ssm | 27 | 444 | 6.1% | cbioportal |
| 25 | MUC4 | Ssm | 26 | 444 | 5.9% | cbioportal |
| 26 | RYR3 | Ssm | 26 | 444 | 5.9% | cbioportal |
| 24 | CDK12 | Ssm | 26 | 444 | 5.9% | cbioportal |
| 29 | RYR2 | Ssm | 25 | 444 | 5.6% | cbioportal |
| 30 | SPOP | Ssm | 25 | 444 | 5.6% | cbioportal |
| 27 | ABCA13 | Ssm | 25 | 444 | 5.6% | cbioportal |
| 28 | MACF1 | Ssm | 25 | 444 | 5.6% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
150 cases with simple somatic mutation data · 150 cases total · 2026-01-16 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | MUC4 | Ssm | 60 | 150 | 40% | cbioportal |
| 2 | TP53 | Ssm | 58 | 150 | 38.7% | cbioportal |
| 3 | TTN | Ssm | 41 | 150 | 27.3% | cbioportal |
| 4 | MUC16 | Ssm | 35 | 150 | 23.3% | cbioportal |
| 5 | AR | Ssm | 27 | 150 | 18% | cbioportal |
| 6 | KMT2C | Ssm | 23 | 150 | 15.3% | cbioportal |
| 7 | SYNE1 | Ssm | 21 | 150 | 14% | cbioportal |
| 8 | KMT2D | Ssm | 18 | 150 | 12% | cbioportal |
| 9 | FOXA1 | Ssm | 16 | 150 | 10.7% | cbioportal |
| 10 | MUC2 | Ssm | 15 | 150 | 10% | cbioportal |
| 14 | USH2A | Ssm | 14 | 150 | 9.3% | cbioportal |
| 11 | CSMD3 | Ssm | 14 | 150 | 9.3% | cbioportal |
| 13 | PIEZO1 | Ssm | 14 | 150 | 9.3% | cbioportal |
| 12 | FAT4 | Ssm | 14 | 150 | 9.3% | cbioportal |
| 16 | PLEC | Ssm | 13 | 150 | 8.7% | cbioportal |
| 15 | CSMD1 | Ssm | 13 | 150 | 8.7% | cbioportal |
| 17 | APC | Ssm | 12 | 150 | 8% | cbioportal |
| 18 | LRP1B | Ssm | 12 | 150 | 8% | cbioportal |
| 19 | SPOP | Ssm | 12 | 150 | 8% | cbioportal |
| 23 | DNAH3 | Ssm | 11 | 150 | 7.3% | cbioportal |
| 24 | HMCN1 | Ssm | 11 | 150 | 7.3% | cbioportal |
| 22 | DCHS2 | Ssm | 11 | 150 | 7.3% | cbioportal |
| 21 | CNTNAP5 | Ssm | 11 | 150 | 7.3% | cbioportal |
| 25 | MUC5B | Ssm | 11 | 150 | 7.3% | cbioportal |
| 26 | OBSCN | Ssm | 11 | 150 | 7.3% | cbioportal |
| 27 | PKHD1L1 | Ssm | 11 | 150 | 7.3% | cbioportal |
| 28 | PREX2 | Ssm | 11 | 150 | 7.3% | cbioportal |
| 29 | PTEN | Ssm | 11 | 150 | 7.3% | cbioportal |
| 30 | RYR1 | Ssm | 11 | 150 | 7.3% | cbioportal |
| 31 | RYR3 | Ssm | 11 | 150 | 7.3% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
114 cases with simple somatic mutation data · 114 cases total · 2026-01-08 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 27 | 114 | 23.7% | cbioportal |
| 2 | TTN | Ssm | 21 | 114 | 18.4% | cbioportal |
| 3 | SPOP | Ssm | 13 | 114 | 11.4% | cbioportal |
| 4 | MUC16 | Ssm | 11 | 114 | 9.6% | cbioportal |
| 5 | OBSCN | Ssm | 10 | 114 | 8.8% | cbioportal |
| 10 | ZNF208 | Ssm | 9 | 114 | 7.9% | cbioportal |
| 7 | HMCN1 | Ssm | 9 | 114 | 7.9% | cbioportal |
| 8 | SHANK1 | Ssm | 9 | 114 | 7.9% | cbioportal |
| 9 | TMC8 | Ssm | 9 | 114 | 7.9% | cbioportal |
| 11 | ZNF626 | Ssm | 9 | 114 | 7.9% | cbioportal |
| 12 | ZNF729 | Ssm | 9 | 114 | 7.9% | cbioportal |
| 6 | FOXA1 | Ssm | 9 | 114 | 7.9% | cbioportal |
| 20 | RB1 | Ssm | 8 | 114 | 7% | cbioportal |
| 13 | CPD | Ssm | 8 | 114 | 7% | cbioportal |
| 21 | ZNFX1 | Ssm | 8 | 114 | 7% | cbioportal |
| 16 | FSIP2 | Ssm | 8 | 114 | 7% | cbioportal |
| 15 | DYNC1H1 | Ssm | 8 | 114 | 7% | cbioportal |
| 17 | KMO | Ssm | 8 | 114 | 7% | cbioportal |
| 18 | LTBP1 | Ssm | 8 | 114 | 7% | cbioportal |
| 14 | DNAH3 | Ssm | 8 | 114 | 7% | cbioportal |
| 19 | METTL24 | Ssm | 8 | 114 | 7% | cbioportal |
| 29 | PIWIL2 | Ssm | 7 | 114 | 6.1% | cbioportal |
| 22 | ADRM1 | Ssm | 7 | 114 | 6.1% | cbioportal |
| 23 | CHRNA3 | Ssm | 7 | 114 | 6.1% | cbioportal |
| 24 | COL14A1 | Ssm | 7 | 114 | 6.1% | cbioportal |
| 25 | CSMD3 | Ssm | 7 | 114 | 6.1% | cbioportal |
| 26 | NBPF3 | Ssm | 7 | 114 | 6.1% | cbioportal |
| 27 | NR2E1 | Ssm | 7 | 114 | 6.1% | cbioportal |
| 28 | OR9A4 | Ssm | 7 | 114 | 6.1% | cbioportal |
| 30 | SLC44A5 | Ssm | 7 | 114 | 6.1% | cbioportal |
Data updated 22 days agoSource updated 2026-01-08
500 cases with simple somatic mutation data · 500 cases total · Data Release 46.0 · mapped to Prostate Adenocarcinoma ONTOLOGY_EXACT
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | CCAR2 | Ssm | 298 | 500 | 59.6% | gdc |
| 2 | XPO7 | Ssm | 297 | 500 | 59.4% | gdc |
| 4 | C8orf58 | Ssm | 297 | 500 | 59.4% | gdc |
| 3 | BIN3 | Ssm | 297 | 500 | 59.4% | gdc |
| 9 | PPP3CC | Ssm | 296 | 500 | 59.2% | gdc |
| 8 | BMP1 | Ssm | 296 | 500 | 59.2% | gdc |
| 7 | PIWIL2 | Ssm | 296 | 500 | 59.2% | gdc |
| 6 | RHOBTB2 | Ssm | 296 | 500 | 59.2% | gdc |
| 5 | SORBS3 | Ssm | 296 | 500 | 59.2% | gdc |
| 12 | PEBP4 | Ssm | 296 | 500 | 59.2% | gdc |
| 11 | AC037459.1 | Ssm | 296 | 500 | 59.2% | gdc |
| 10 | TNFRSF10C | Ssm | 296 | 500 | 59.2% | gdc |
| 18 | DOK2 | Ssm | 295 | 500 | 59% | gdc |
| 23 | TNFRSF10A | Ssm | 295 | 500 | 59% | gdc |
| 22 | PDLIM2 | Ssm | 295 | 500 | 59% | gdc |
| 21 | FAM160B2 | Ssm | 295 | 500 | 59% | gdc |
| 20 | TNFRSF10D | Ssm | 295 | 500 | 59% | gdc |
| 19 | POLR3D | Ssm | 295 | 500 | 59% | gdc |
| 14 | AC107959.5 | Ssm | 295 | 500 | 59% | gdc |
| 17 | DMTN | Ssm | 295 | 500 | 59% | gdc |
| 16 | REEP4 | Ssm | 295 | 500 | 59% | gdc |
| 15 | EGR3 | Ssm | 295 | 500 | 59% | gdc |
| 13 | HR | Ssm | 295 | 500 | 59% | gdc |
| 26 | NKX3-1 | Ssm | 294 | 500 | 58.8% | gdc |
| 25 | TNFRSF10B | Ssm | 294 | 500 | 58.8% | gdc |
| 24 | CHMP7 | Ssm | 294 | 500 | 58.8% | gdc |
| 30 | SLC25A37 | Ssm | 294 | 500 | 58.8% | gdc |
| 29 | R3HCC1 | Ssm | 294 | 500 | 58.8% | gdc |
| 28 | NPM2 | Ssm | 294 | 500 | 58.8% | gdc |
| 27 | LGI3 | Ssm | 294 | 500 | 58.8% | gdc |
Data updated 23 days agoSource updated Data Release 46.0
57 cases with simple somatic mutation data · 82 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | MUC4 | Ssm | 7 | 57 | 12.3% | cbioportal |
| 4 | TP53 | Ssm | 6 | 57 | 10.5% | cbioportal |
| 2 | ATM | Ssm | 6 | 57 | 10.5% | cbioportal |
| 3 | MUC16 | Ssm | 6 | 57 | 10.5% | cbioportal |
| 6 | KMT2C | Ssm | 5 | 57 | 8.8% | cbioportal |
| 5 | FOXA1 | Ssm | 5 | 57 | 8.8% | cbioportal |
| 7 | MACF1 | Ssm | 5 | 57 | 8.8% | cbioportal |
| 13 | ZAN | Ssm | 4 | 57 | 7% | cbioportal |
| 9 | FLG | Ssm | 4 | 57 | 7% | cbioportal |
| 10 | PLCB3 | Ssm | 4 | 57 | 7% | cbioportal |
| 11 | SPOP | Ssm | 4 | 57 | 7% | cbioportal |
| 12 | TTN | Ssm | 4 | 57 | 7% | cbioportal |
| 8 | BRINP2 | Ssm | 4 | 57 | 7% | cbioportal |
| 32 | POTEF | Ssm | 3 | 57 | 5.3% | cbioportal |
| 26 | FASN | Ssm | 3 | 57 | 5.3% | cbioportal |
| 25 | DYNC2I1 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 24 | DMD | Ssm | 3 | 57 | 5.3% | cbioportal |
| 23 | CSMD3 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 22 | CS | Ssm | 3 | 57 | 5.3% | cbioportal |
| 21 | CREB3L4 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 20 | CLIC6 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 19 | CD8B | Ssm | 3 | 57 | 5.3% | cbioportal |
| 14 | ABCC9 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 15 | ANK2 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 18 | C10ORF90 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 16 | APC | Ssm | 3 | 57 | 5.3% | cbioportal |
| 36 | TNXB | Ssm | 3 | 57 | 5.3% | cbioportal |
| 35 | SUZ12 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 34 | SIPA1L1 | Ssm | 3 | 57 | 5.3% | cbioportal |
| 33 | PRDM9 | Ssm | 3 | 57 | 5.3% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
112 cases with simple somatic mutation data · 123 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | SPOP | Ssm | 14 | 112 | 12.5% | cbioportal |
| 2 | TTN | Ssm | 11 | 112 | 9.8% | cbioportal |
| 4 | TP53 | Ssm | 7 | 112 | 6.3% | cbioportal |
| 3 | THSD7B | Ssm | 7 | 112 | 6.3% | cbioportal |
| 9 | SPTA1 | Ssm | 6 | 112 | 5.4% | cbioportal |
| 5 | FAT4 | Ssm | 6 | 112 | 5.4% | cbioportal |
| 6 | HMCN1 | Ssm | 6 | 112 | 5.4% | cbioportal |
| 7 | MED12 | Ssm | 6 | 112 | 5.4% | cbioportal |
| 8 | SCN11A | Ssm | 6 | 112 | 5.4% | cbioportal |
| 13 | MDN1 | Ssm | 5 | 112 | 4.5% | cbioportal |
| 12 | FLG | Ssm | 5 | 112 | 4.5% | cbioportal |
| 11 | FAT1 | Ssm | 5 | 112 | 4.5% | cbioportal |
| 10 | ABCA13 | Ssm | 5 | 112 | 4.5% | cbioportal |
| 14 | NBAS | Ssm | 5 | 112 | 4.5% | cbioportal |
| 15 | OBSCN | Ssm | 5 | 112 | 4.5% | cbioportal |
| 16 | PTEN | Ssm | 5 | 112 | 4.5% | cbioportal |
| 17 | SYNE3 | Ssm | 5 | 112 | 4.5% | cbioportal |
| 28 | LRP1B | Ssm | 4 | 112 | 3.6% | cbioportal |
| 27 | ITPR1 | Ssm | 4 | 112 | 3.6% | cbioportal |
| 26 | FRAS1 | Ssm | 4 | 112 | 3.6% | cbioportal |
| 30 | MYO18B | Ssm | 4 | 112 | 3.6% | cbioportal |
| 29 | MUC16 | Ssm | 4 | 112 | 3.6% | cbioportal |
| 25 | FOXA1 | Ssm | 4 | 112 | 3.6% | cbioportal |
| 24 | FNDC1 | Ssm | 4 | 112 | 3.6% | cbioportal |
| 23 | FMN2 | Ssm | 4 | 112 | 3.6% | cbioportal |
| 22 | DISP3 | Ssm | 4 | 112 | 3.6% | cbioportal |
| 18 | CACNA1E | Ssm | 4 | 112 | 3.6% | cbioportal |
| 19 | CD1A | Ssm | 4 | 112 | 3.6% | cbioportal |
| 20 | CTNNA2 | Ssm | 4 | 112 | 3.6% | cbioportal |
| 21 | CUX1 | Ssm | 4 | 112 | 3.6% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
477 cases with simple somatic mutation data · 477 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | SPOP | Ssm | 38 | 477 | 8% | cbioportal |
| 2 | TTN | Ssm | 21 | 477 | 4.4% | cbioportal |
| 3 | TP53 | Ssm | 16 | 477 | 3.4% | cbioportal |
| 4 | MUC16 | Ssm | 12 | 477 | 2.5% | cbioportal |
| 6 | MED12 | Ssm | 11 | 477 | 2.3% | cbioportal |
| 5 | FOXA1 | Ssm | 11 | 477 | 2.3% | cbioportal |
| 7 | C6 | Ssm | 9 | 477 | 1.9% | cbioportal |
| 10 | RYR2 | Ssm | 9 | 477 | 1.9% | cbioportal |
| 9 | QRICH2 | Ssm | 9 | 477 | 1.9% | cbioportal |
| 8 | PRB4 | Ssm | 9 | 477 | 1.9% | cbioportal |
| 12 | KMT2C | Ssm | 8 | 477 | 1.7% | cbioportal |
| 11 | ATM | Ssm | 8 | 477 | 1.7% | cbioportal |
| 15 | TPTE | Ssm | 7 | 477 | 1.5% | cbioportal |
| 14 | SYNE1 | Ssm | 7 | 477 | 1.5% | cbioportal |
| 13 | PCDH15 | Ssm | 7 | 477 | 1.5% | cbioportal |
| 21 | SPTA1 | Ssm | 6 | 477 | 1.3% | cbioportal |
| 18 | C9 | Ssm | 6 | 477 | 1.3% | cbioportal |
| 17 | AHNAK2 | Ssm | 6 | 477 | 1.3% | cbioportal |
| 16 | ADAMTS20 | Ssm | 6 | 477 | 1.3% | cbioportal |
| 19 | CSMD3 | Ssm | 6 | 477 | 1.3% | cbioportal |
| 20 | FAT3 | Ssm | 6 | 477 | 1.3% | cbioportal |
| 22 | ANK2 | Ssm | 5 | 477 | 1% | cbioportal |
| 23 | C3 | Ssm | 5 | 477 | 1% | cbioportal |
| 24 | C7 | Ssm | 5 | 477 | 1% | cbioportal |
| 25 | CFAP65 | Ssm | 5 | 477 | 1% | cbioportal |
| 26 | CNTNAP5 | Ssm | 5 | 477 | 1% | cbioportal |
| 27 | COL11A1 | Ssm | 5 | 477 | 1% | cbioportal |
| 28 | DCAF4L2 | Ssm | 5 | 477 | 1% | cbioportal |
| 29 | FAT1 | Ssm | 5 | 477 | 1% | cbioportal |
| 30 | FNDC1 | Ssm | 5 | 477 | 1% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
141 cases with simple somatic mutation data · 176 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 57 | 141 | 40.4% | cbioportal |
| 5 | TTN | Ssm | 18 | 141 | 12.8% | cbioportal |
| 2 | CSMD3 | Ssm | 18 | 141 | 12.8% | cbioportal |
| 4 | RNF213 | Ssm | 18 | 141 | 12.8% | cbioportal |
| 3 | MUC16 | Ssm | 18 | 141 | 12.8% | cbioportal |
| 6 | DCHS2 | Ssm | 17 | 141 | 12.1% | cbioportal |
| 7 | OBSCN | Ssm | 17 | 141 | 12.1% | cbioportal |
| 8 | ATM | Ssm | 16 | 141 | 11.3% | cbioportal |
| 11 | RYR2 | Ssm | 16 | 141 | 11.3% | cbioportal |
| 10 | LRP1B | Ssm | 16 | 141 | 11.3% | cbioportal |
| 9 | HERC2 | Ssm | 16 | 141 | 11.3% | cbioportal |
| 13 | DNAH6 | Ssm | 15 | 141 | 10.6% | cbioportal |
| 12 | CDH11 | Ssm | 15 | 141 | 10.6% | cbioportal |
| 15 | ZFHX3 | Ssm | 15 | 141 | 10.6% | cbioportal |
| 14 | TICRR | Ssm | 15 | 141 | 10.6% | cbioportal |
| 19 | PCDHA6 | Ssm | 14 | 141 | 9.9% | cbioportal |
| 18 | KMT2D | Ssm | 14 | 141 | 9.9% | cbioportal |
| 17 | CENPF | Ssm | 14 | 141 | 9.9% | cbioportal |
| 16 | ABCA13 | Ssm | 14 | 141 | 9.9% | cbioportal |
| 21 | SPTA1 | Ssm | 14 | 141 | 9.9% | cbioportal |
| 20 | PLCG1 | Ssm | 14 | 141 | 9.9% | cbioportal |
| 24 | LRRK2 | Ssm | 13 | 141 | 9.2% | cbioportal |
| 22 | DNAH1 | Ssm | 13 | 141 | 9.2% | cbioportal |
| 26 | SYNE1 | Ssm | 13 | 141 | 9.2% | cbioportal |
| 25 | SKIC3 | Ssm | 13 | 141 | 9.2% | cbioportal |
| 23 | HECTD1 | Ssm | 13 | 141 | 9.2% | cbioportal |
| 28 | C7 | Ssm | 12 | 141 | 8.5% | cbioportal |
| 30 | DYNC2H1 | Ssm | 12 | 141 | 8.5% | cbioportal |
| 29 | CDH12 | Ssm | 12 | 141 | 8.5% | cbioportal |
| 27 | APOBEC3G | Ssm | 12 | 141 | 8.5% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
120 cases with simple somatic mutation data · 120 cases total · 2026-03-04 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 31 | 120 | 25.8% | cbioportal |
| 2 | BRCA2 | Ssm | 22 | 120 | 18.3% | cbioportal |
| 3 | ZFHX3 | Ssm | 15 | 116 | 12.9% | cbioportal |
| 4 | FOXA1 | Ssm | 14 | 120 | 11.7% | cbioportal |
| 5 | KMT2C | Ssm | 14 | 120 | 11.7% | cbioportal |
| 6 | CDK12 | Ssm | 12 | 120 | 10% | cbioportal |
| 7 | ATM | Ssm | 10 | 120 | 8.3% | cbioportal |
| 8 | KMT2D | Ssm | 9 | 120 | 7.5% | cbioportal |
| 9 | SPOP | Ssm | 9 | 120 | 7.5% | cbioportal |
| 10 | SPEN | Ssm | 8 | 120 | 6.7% | cbioportal |
| 14 | MGA | Ssm | 7 | 116 | 6% | cbioportal |
| 12 | AR | Ssm | 7 | 120 | 5.8% | cbioportal |
| 11 | APC | Ssm | 7 | 120 | 5.8% | cbioportal |
| 13 | BRCA1 | Ssm | 7 | 120 | 5.8% | cbioportal |
| 27 | TP53BP1 | Ssm | 5 | 90 | 5.6% | cbioportal |
| 20 | PTPRD | Ssm | 6 | 120 | 5% | cbioportal |
| 15 | CTNNB1 | Ssm | 6 | 120 | 5% | cbioportal |
| 16 | KMT2A | Ssm | 6 | 120 | 5% | cbioportal |
| 17 | NCOR1 | Ssm | 6 | 120 | 5% | cbioportal |
| 18 | PTCH1 | Ssm | 6 | 120 | 5% | cbioportal |
| 19 | PTEN | Ssm | 6 | 120 | 5% | cbioportal |
| 184 | GNB1 | Ssm | 1 | 22 | 4.5% | cbioportal |
| 150 | ARHGAP35 | Ssm | 1 | 22 | 4.5% | cbioportal |
| 31 | CARM1 | Ssm | 4 | 90 | 4.4% | cbioportal |
| 35 | ERF | Ssm | 4 | 90 | 4.4% | cbioportal |
| 21 | ANKRD11 | Ssm | 5 | 116 | 4.3% | cbioportal |
| 24 | NOTCH2 | Ssm | 5 | 120 | 4.2% | cbioportal |
| 23 | MED12 | Ssm | 5 | 120 | 4.2% | cbioportal |
| 26 | SMARCA4 | Ssm | 5 | 120 | 4.2% | cbioportal |
| 22 | KDM6A | Ssm | 5 | 120 | 4.2% | cbioportal |
Data updated 22 days agoSource updated 2026-03-04
182 cases with simple somatic mutation data · 240 cases total · 2026-02-19 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 66 | ROS1 | Ssm | 2 | 9 | 22.2% | cbioportal |
| 69 | STAT5B | Ssm | 2 | 9 | 22.2% | cbioportal |
| 80 | EGF | Ssm | 1 | 9 | 11.1% | cbioportal |
| 115 | RAC3 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 119 | SRC | Ssm | 1 | 9 | 11.1% | cbioportal |
| 120 | STAT1 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 121 | TYK2 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 111 | PTK2 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 92 | JAK2 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 107 | PDGFRB | Ssm | 1 | 9 | 11.1% | cbioportal |
| 106 | NSD1 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 103 | MUTYH | Ssm | 1 | 9 | 11.1% | cbioportal |
| 100 | MAPK7 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 97 | LCK | Ssm | 1 | 9 | 11.1% | cbioportal |
| 90 | IDH2 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 89 | FGF1 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 88 | FES | Ssm | 1 | 9 | 11.1% | cbioportal |
| 85 | ETS2 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 81 | ELK1 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 110 | PRKCZ | Ssm | 1 | 9 | 11.1% | cbioportal |
| 114 | PTPN6 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 78 | CASP9 | Ssm | 1 | 9 | 11.1% | cbioportal |
| 75 | BLK | Ssm | 1 | 9 | 11.1% | cbioportal |
| 1 | PTPRF | Ssm | 9 | 106 | 8.5% | cbioportal |
| 2 | EP300 | Ssm | 7 | 106 | 6.6% | cbioportal |
| 4 | FLT4 | Ssm | 6 | 106 | 5.7% | cbioportal |
| 3 | AR | Ssm | 6 | 106 | 5.7% | cbioportal |
| 11 | PTPN14 | Ssm | 5 | 106 | 4.7% | cbioportal |
| 6 | AXL | Ssm | 5 | 106 | 4.7% | cbioportal |
| 7 | EPS15 | Ssm | 5 | 106 | 4.7% | cbioportal |
Data updated 22 days agoSource updated 2026-02-19
1,417 cases with simple somatic mutation data · 1,417 cases total · 2026-01-16 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 411 | 1,417 | 29% | cbioportal |
| 2 | SPOP | Ssm | 200 | 1,417 | 14.1% | cbioportal |
| 3 | FOXA1 | Ssm | 197 | 1,417 | 13.9% | cbioportal |
| 4 | APC | Ssm | 124 | 1,417 | 8.8% | cbioportal |
| 5 | PTEN | Ssm | 119 | 1,417 | 8.4% | cbioportal |
| 6 | KMT2C | Ssm | 81 | 1,417 | 5.7% | cbioportal |
| 8 | ZFHX3 | Ssm | 75 | 1,361 | 5.5% | cbioportal |
| 7 | KMT2D | Ssm | 76 | 1,417 | 5.4% | cbioportal |
| 9 | CDK12 | Ssm | 67 | 1,417 | 4.7% | cbioportal |
| 10 | CTNNB1 | Ssm | 61 | 1,417 | 4.3% | cbioportal |
| 11 | PIK3CA | Ssm | 60 | 1,417 | 4.2% | cbioportal |
| 12 | ATM | Ssm | 59 | 1,417 | 4.2% | cbioportal |
| 13 | BRCA2 | Ssm | 56 | 1,417 | 4% | cbioportal |
| 14 | AR | Ssm | 53 | 1,417 | 3.7% | cbioportal |
| 15 | PIK3R1 | Ssm | 48 | 1,417 | 3.4% | cbioportal |
| 16 | KDM6A | Ssm | 44 | 1,417 | 3.1% | cbioportal |
| 17 | MGA | Ssm | 39 | 1,361 | 2.9% | cbioportal |
| 18 | RB1 | Ssm | 36 | 1,417 | 2.5% | cbioportal |
| 19 | MED12 | Ssm | 35 | 1,417 | 2.5% | cbioportal |
| 20 | PTPRD | Ssm | 31 | 1,417 | 2.2% | cbioportal |
| 21 | GRIN2A | Ssm | 28 | 1,417 | 2% | cbioportal |
| 22 | ASXL2 | Ssm | 27 | 1,417 | 1.9% | cbioportal |
| 24 | JAK1 | Ssm | 26 | 1,417 | 1.8% | cbioportal |
| 23 | EPHB1 | Ssm | 26 | 1,417 | 1.8% | cbioportal |
| 25 | SPEN | Ssm | 26 | 1,417 | 1.8% | cbioportal |
| 27 | SF3B1 | Ssm | 25 | 1,417 | 1.8% | cbioportal |
| 26 | NCOR1 | Ssm | 25 | 1,417 | 1.8% | cbioportal |
| 28 | ARID1A | Ssm | 23 | 1,417 | 1.6% | cbioportal |
| 29 | ASXL1 | Ssm | 22 | 1,417 | 1.6% | cbioportal |
| 30 | BRAF | Ssm | 22 | 1,417 | 1.6% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
1,013 cases with simple somatic mutation data · 1,013 cases total · 2026-01-16 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 189 | 1,013 | 18.7% | cbioportal |
| 2 | TTN | Ssm | 151 | 1,013 | 14.9% | cbioportal |
| 3 | MUC16 | Ssm | 113 | 1,013 | 11.2% | cbioportal |
| 4 | SPOP | Ssm | 92 | 1,013 | 9.1% | cbioportal |
| 5 | SYNE1 | Ssm | 73 | 1,013 | 7.2% | cbioportal |
| 6 | FOXA1 | Ssm | 69 | 1,013 | 6.8% | cbioportal |
| 7 | KMT2C | Ssm | 66 | 1,013 | 6.5% | cbioportal |
| 8 | KMT2D | Ssm | 65 | 1,013 | 6.4% | cbioportal |
| 9 | CSMD3 | Ssm | 61 | 1,013 | 6% | cbioportal |
| 10 | HMCN1 | Ssm | 55 | 1,013 | 5.4% | cbioportal |
| 11 | LRP1B | Ssm | 54 | 1,013 | 5.3% | cbioportal |
| 12 | OBSCN | Ssm | 53 | 1,013 | 5.2% | cbioportal |
| 13 | AR | Ssm | 48 | 1,013 | 4.7% | cbioportal |
| 14 | SPTA1 | Ssm | 47 | 1,013 | 4.6% | cbioportal |
| 15 | USH2A | Ssm | 46 | 1,013 | 4.5% | cbioportal |
| 16 | RYR1 | Ssm | 45 | 1,013 | 4.4% | cbioportal |
| 18 | RYR2 | Ssm | 44 | 1,013 | 4.3% | cbioportal |
| 17 | PTEN | Ssm | 44 | 1,013 | 4.3% | cbioportal |
| 19 | ABCA13 | Ssm | 43 | 1,013 | 4.2% | cbioportal |
| 20 | FAT3 | Ssm | 41 | 1,013 | 4% | cbioportal |
| 21 | ZFHX3 | Ssm | 41 | 1,013 | 4% | cbioportal |
| 22 | DCHS2 | Ssm | 40 | 1,013 | 3.9% | cbioportal |
| 23 | FAT4 | Ssm | 39 | 1,013 | 3.8% | cbioportal |
| 24 | ATM | Ssm | 38 | 1,013 | 3.8% | cbioportal |
| 26 | CSMD1 | Ssm | 37 | 1,013 | 3.7% | cbioportal |
| 25 | CACNA1E | Ssm | 37 | 1,013 | 3.7% | cbioportal |
| 27 | DNAH3 | Ssm | 36 | 1,013 | 3.6% | cbioportal |
| 29 | MYO15A | Ssm | 34 | 1,013 | 3.4% | cbioportal |
| 30 | XIRP2 | Ssm | 34 | 1,013 | 3.4% | cbioportal |
| 28 | MUC4 | Ssm | 34 | 1,013 | 3.4% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
1,465 cases with simple somatic mutation data · 1,465 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 391 | 1,465 | 26.7% | cbioportal |
| 2 | FOXA1 | Ssm | 179 | 1,465 | 12.2% | cbioportal |
| 3 | SPOP | Ssm | 166 | 1,465 | 11.3% | cbioportal |
| 4 | PTEN | Ssm | 97 | 1,465 | 6.6% | cbioportal |
| 5 | KMT2C | Ssm | 89 | 1,465 | 6.1% | cbioportal |
| 6 | CDK12 | Ssm | 88 | 1,465 | 6% | cbioportal |
| 7 | APC | Ssm | 86 | 1,465 | 5.9% | cbioportal |
| 8 | KMT2D | Ssm | 74 | 1,465 | 5.1% | cbioportal |
| 9 | AR | Ssm | 56 | 1,465 | 3.8% | cbioportal |
| 13 | ZFHX3 | Ssm | 51 | 1,337 | 3.8% | cbioportal |
| 10 | CTNNB1 | Ssm | 55 | 1,465 | 3.8% | cbioportal |
| 12 | PIK3CA | Ssm | 52 | 1,465 | 3.5% | cbioportal |
| 11 | ATM | Ssm | 52 | 1,465 | 3.5% | cbioportal |
| 14 | BRCA2 | Ssm | 45 | 1,465 | 3.1% | cbioportal |
| 15 | KDM6A | Ssm | 38 | 1,465 | 2.6% | cbioportal |
| 16 | GRIN2A | Ssm | 36 | 1,465 | 2.5% | cbioportal |
| 17 | MED12 | Ssm | 31 | 1,465 | 2.1% | cbioportal |
| 18 | PTPRD | Ssm | 30 | 1,465 | 2% | cbioportal |
| 19 | SPEN | Ssm | 28 | 1,465 | 1.9% | cbioportal |
| 20 | RB1 | Ssm | 27 | 1,465 | 1.8% | cbioportal |
| 24 | MGA | Ssm | 24 | 1,337 | 1.8% | cbioportal |
| 21 | BRAF | Ssm | 26 | 1,465 | 1.8% | cbioportal |
| 48 | ERF | Ssm | 14 | 809 | 1.7% | cbioportal |
| 22 | PIK3R1 | Ssm | 25 | 1,465 | 1.7% | cbioportal |
| 23 | ASXL1 | Ssm | 24 | 1,465 | 1.6% | cbioportal |
| 25 | NCOR1 | Ssm | 24 | 1,465 | 1.6% | cbioportal |
| 27 | JAK1 | Ssm | 23 | 1,465 | 1.6% | cbioportal |
| 29 | NF1 | Ssm | 23 | 1,465 | 1.6% | cbioportal |
| 26 | ARID1A | Ssm | 23 | 1,465 | 1.6% | cbioportal |
| 28 | KMT2A | Ssm | 23 | 1,465 | 1.6% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
12 cases with simple somatic mutation data · 12 cases total · 2026-01-16 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 7 | 12 | 58.3% | cbioportal |
| 2 | TBP | Ssm | 6 | 12 | 50% | cbioportal |
| 3 | LCE4A | Ssm | 4 | 12 | 33.3% | cbioportal |
| 16 | TRIOBP | Ssm | 3 | 12 | 25% | cbioportal |
| 13 | SCN5A | Ssm | 3 | 12 | 25% | cbioportal |
| 4 | ABHD15 | Ssm | 3 | 12 | 25% | cbioportal |
| 5 | ATXN1 | Ssm | 3 | 12 | 25% | cbioportal |
| 6 | CRACD | Ssm | 3 | 12 | 25% | cbioportal |
| 7 | FOXA1 | Ssm | 3 | 12 | 25% | cbioportal |
| 8 | GIT2 | Ssm | 3 | 12 | 25% | cbioportal |
| 9 | KIRREL1 | Ssm | 3 | 12 | 25% | cbioportal |
| 10 | KRT1 | Ssm | 3 | 12 | 25% | cbioportal |
| 11 | KRT72 | Ssm | 3 | 12 | 25% | cbioportal |
| 12 | NKX6-2 | Ssm | 3 | 12 | 25% | cbioportal |
| 14 | SPATA3 | Ssm | 3 | 12 | 25% | cbioportal |
| 15 | SPATA31D1 | Ssm | 3 | 12 | 25% | cbioportal |
| 23 | ANK2 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 17 | A1BG | Ssm | 2 | 12 | 16.7% | cbioportal |
| 18 | ACTL9 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 19 | ADAMTS12 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 20 | ADCY1 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 21 | AEBP1 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 22 | AGO3 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 24 | ANO1 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 25 | APOL4 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 26 | ARGFX | Ssm | 2 | 12 | 16.7% | cbioportal |
| 27 | ARID3B | Ssm | 2 | 12 | 16.7% | cbioportal |
| 28 | ART5 | Ssm | 2 | 12 | 16.7% | cbioportal |
| 29 | ASPM | Ssm | 2 | 12 | 16.7% | cbioportal |
| 30 | BLTP3B | Ssm | 2 | 12 | 16.7% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
65 cases with simple somatic mutation data · 65 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | SPOP | Ssm | 11 | 65 | 16.9% | cbioportal |
| 2 | KDM6A | Ssm | 5 | 65 | 7.7% | cbioportal |
| 3 | KMT2D | Ssm | 4 | 65 | 6.2% | cbioportal |
| 8 | SEMA5A | Ssm | 3 | 65 | 4.6% | cbioportal |
| 7 | RYR1 | Ssm | 3 | 65 | 4.6% | cbioportal |
| 5 | MYH2 | Ssm | 3 | 65 | 4.6% | cbioportal |
| 6 | PTEN | Ssm | 3 | 65 | 4.6% | cbioportal |
| 4 | COL22A1 | Ssm | 3 | 65 | 4.6% | cbioportal |
| 9 | TP53 | Ssm | 3 | 65 | 4.6% | cbioportal |
| 19 | CFAP69 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 12 | AKR1A1 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 11 | ADCY8 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 10 | ADAM2 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 26 | CSF1R | Ssm | 2 | 65 | 3.1% | cbioportal |
| 14 | ATM | Ssm | 2 | 65 | 3.1% | cbioportal |
| 15 | BOC | Ssm | 2 | 65 | 3.1% | cbioportal |
| 16 | C2 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 17 | CAMTA1 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 18 | CDK12 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 13 | ALOX5 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 20 | CHD6 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 21 | CLCNKA | Ssm | 2 | 65 | 3.1% | cbioportal |
| 22 | COL16A1 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 23 | COL4A1 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 24 | COL4A2 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 25 | CPOX | Ssm | 2 | 65 | 3.1% | cbioportal |
| 27 | CSMD1 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 28 | CTNNB1 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 29 | CUL3 | Ssm | 2 | 65 | 3.1% | cbioportal |
| 30 | DNAH10 | Ssm | 2 | 65 | 3.1% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
333 cases with simple somatic mutation data · 333 cases total · 2026-01-16 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | SPOP | Ssm | 37 | 333 | 11.1% | cbioportal |
| 2 | TTN | Ssm | 37 | 333 | 11.1% | cbioportal |
| 3 | TP53 | Ssm | 23 | 333 | 6.9% | cbioportal |
| 4 | MUC16 | Ssm | 20 | 333 | 6% | cbioportal |
| 5 | MUC17 | Ssm | 17 | 333 | 5.1% | cbioportal |
| 6 | SPTA1 | Ssm | 15 | 333 | 4.5% | cbioportal |
| 7 | ATM | Ssm | 13 | 333 | 3.9% | cbioportal |
| 9 | KMT2C | Ssm | 13 | 333 | 3.9% | cbioportal |
| 8 | FOXA1 | Ssm | 13 | 333 | 3.9% | cbioportal |
| 10 | AHNAK2 | Ssm | 12 | 333 | 3.6% | cbioportal |
| 12 | LRP1B | Ssm | 12 | 333 | 3.6% | cbioportal |
| 11 | CSMD3 | Ssm | 12 | 333 | 3.6% | cbioportal |
| 14 | OBSCN | Ssm | 11 | 333 | 3.3% | cbioportal |
| 13 | KMT2D | Ssm | 11 | 333 | 3.3% | cbioportal |
| 16 | FAT3 | Ssm | 10 | 333 | 3% | cbioportal |
| 18 | RP1 | Ssm | 10 | 333 | 3% | cbioportal |
| 17 | HMCN1 | Ssm | 10 | 333 | 3% | cbioportal |
| 15 | AHNAK | Ssm | 10 | 333 | 3% | cbioportal |
| 22 | PTEN | Ssm | 9 | 333 | 2.7% | cbioportal |
| 19 | BRCA2 | Ssm | 9 | 333 | 2.7% | cbioportal |
| 21 | FLG2 | Ssm | 9 | 333 | 2.7% | cbioportal |
| 20 | DCHS2 | Ssm | 9 | 333 | 2.7% | cbioportal |
| 30 | PCDH18 | Ssm | 8 | 333 | 2.4% | cbioportal |
| 23 | ADGRB3 | Ssm | 8 | 333 | 2.4% | cbioportal |
| 24 | ADGRV1 | Ssm | 8 | 333 | 2.4% | cbioportal |
| 25 | BRAF | Ssm | 8 | 333 | 2.4% | cbioportal |
| 26 | CTNNB1 | Ssm | 8 | 333 | 2.4% | cbioportal |
| 27 | DNAH9 | Ssm | 8 | 333 | 2.4% | cbioportal |
| 28 | FLG | Ssm | 8 | 333 | 2.4% | cbioportal |
| 29 | MACF1 | Ssm | 8 | 333 | 2.4% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
499 cases with simple somatic mutation data · 501 cases total · 2026-01-16 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | FRG1BP | Ssm | 97 | 499 | 19.4% | cbioportal |
| 2 | TTN | Ssm | 63 | 499 | 12.6% | cbioportal |
| 3 | TP53 | Ssm | 61 | 499 | 12.2% | cbioportal |
| 4 | SPOP | Ssm | 57 | 499 | 11.4% | cbioportal |
| 5 | MUC16 | Ssm | 38 | 499 | 7.6% | cbioportal |
| 6 | MUC17 | Ssm | 33 | 499 | 6.6% | cbioportal |
| 7 | KMT2C | Ssm | 30 | 499 | 6% | cbioportal |
| 8 | KMT2D | Ssm | 29 | 499 | 5.8% | cbioportal |
| 9 | FOXA1 | Ssm | 28 | 499 | 5.6% | cbioportal |
| 10 | NBPF1 | Ssm | 27 | 499 | 5.4% | cbioportal |
| 11 | SYNE1 | Ssm | 27 | 499 | 5.4% | cbioportal |
| 12 | SPTA1 | Ssm | 26 | 499 | 5.2% | cbioportal |
| 13 | KRTAP4-11 | Ssm | 24 | 499 | 4.8% | cbioportal |
| 14 | LRP1B | Ssm | 24 | 499 | 4.8% | cbioportal |
| 15 | NBPF10 | Ssm | 23 | 499 | 4.6% | cbioportal |
| 16 | ATM | Ssm | 22 | 499 | 4.4% | cbioportal |
| 17 | CSMD3 | Ssm | 22 | 499 | 4.4% | cbioportal |
| 18 | ZAN | Ssm | 22 | 499 | 4.4% | cbioportal |
| 19 | CHEK2 | Ssm | 21 | 499 | 4.2% | cbioportal |
| 20 | MUC4 | Ssm | 21 | 499 | 4.2% | cbioportal |
| 21 | FAT3 | Ssm | 19 | 499 | 3.8% | cbioportal |
| 22 | HMCN1 | Ssm | 19 | 499 | 3.8% | cbioportal |
| 23 | RYR1 | Ssm | 19 | 499 | 3.8% | cbioportal |
| 27 | USH2A | Ssm | 18 | 499 | 3.6% | cbioportal |
| 24 | CACNA1E | Ssm | 18 | 499 | 3.6% | cbioportal |
| 25 | OBSCN | Ssm | 18 | 499 | 3.6% | cbioportal |
| 26 | RGPD8 | Ssm | 18 | 499 | 3.6% | cbioportal |
| 28 | MACF1 | Ssm | 17 | 499 | 3.4% | cbioportal |
| 29 | PTEN | Ssm | 17 | 499 | 3.4% | cbioportal |
| 30 | RYR2 | Ssm | 17 | 499 | 3.4% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
491 cases with simple somatic mutation data · 501 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 55 | 491 | 11.2% | cbioportal |
| 2 | SPOP | Ssm | 54 | 491 | 11% | cbioportal |
| 3 | TTN | Ssm | 47 | 491 | 9.6% | cbioportal |
| 4 | FOXA1 | Ssm | 29 | 491 | 5.9% | cbioportal |
| 5 | KMT2D | Ssm | 28 | 491 | 5.7% | cbioportal |
| 6 | MUC16 | Ssm | 26 | 491 | 5.3% | cbioportal |
| 7 | SYNE1 | Ssm | 22 | 491 | 4.5% | cbioportal |
| 8 | KMT2C | Ssm | 21 | 491 | 4.3% | cbioportal |
| 9 | LRP1B | Ssm | 20 | 491 | 4.1% | cbioportal |
| 10 | SPTA1 | Ssm | 20 | 491 | 4.1% | cbioportal |
| 11 | ATM | Ssm | 18 | 491 | 3.7% | cbioportal |
| 13 | RYR2 | Ssm | 17 | 491 | 3.5% | cbioportal |
| 12 | CSMD3 | Ssm | 17 | 491 | 3.5% | cbioportal |
| 14 | PTEN | Ssm | 16 | 491 | 3.3% | cbioportal |
| 15 | KDM6A | Ssm | 15 | 491 | 3.1% | cbioportal |
| 17 | HMCN1 | Ssm | 14 | 491 | 2.9% | cbioportal |
| 16 | CACNA1E | Ssm | 14 | 491 | 2.9% | cbioportal |
| 18 | MUC17 | Ssm | 14 | 491 | 2.9% | cbioportal |
| 19 | RP1 | Ssm | 13 | 491 | 2.6% | cbioportal |
| 20 | USH2A | Ssm | 13 | 491 | 2.6% | cbioportal |
| 22 | MYO15A | Ssm | 12 | 491 | 2.4% | cbioportal |
| 21 | FAT3 | Ssm | 12 | 491 | 2.4% | cbioportal |
| 23 | RYR1 | Ssm | 12 | 491 | 2.4% | cbioportal |
| 24 | ABCA13 | Ssm | 11 | 491 | 2.2% | cbioportal |
| 30 | ZMYM3 | Ssm | 11 | 491 | 2.2% | cbioportal |
| 29 | OBSCN | Ssm | 11 | 491 | 2.2% | cbioportal |
| 28 | MACF1 | Ssm | 11 | 491 | 2.2% | cbioportal |
| 27 | CNTNAP5 | Ssm | 11 | 491 | 2.2% | cbioportal |
| 26 | APC | Ssm | 11 | 491 | 2.2% | cbioportal |
| 25 | ADGRB3 | Ssm | 11 | 491 | 2.2% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
494 cases with simple somatic mutation data · 494 cases total · 2026-06-04 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 57 | 494 | 11.5% | cbioportal |
| 2 | SPOP | Ssm | 55 | 494 | 11.1% | cbioportal |
| 3 | TTN | Ssm | 54 | 494 | 10.9% | cbioportal |
| 4 | MUC16 | Ssm | 31 | 494 | 6.3% | cbioportal |
| 5 | FOXA1 | Ssm | 28 | 494 | 5.7% | cbioportal |
| 6 | KMT2D | Ssm | 28 | 494 | 5.7% | cbioportal |
| 7 | KMT2C | Ssm | 25 | 494 | 5.1% | cbioportal |
| 8 | SPTA1 | Ssm | 23 | 494 | 4.7% | cbioportal |
| 9 | SYNE1 | Ssm | 23 | 494 | 4.7% | cbioportal |
| 10 | LRP1B | Ssm | 22 | 494 | 4.5% | cbioportal |
| 11 | ATM | Ssm | 20 | 494 | 4% | cbioportal |
| 12 | CSMD3 | Ssm | 19 | 494 | 3.8% | cbioportal |
| 13 | FAT3 | Ssm | 18 | 494 | 3.6% | cbioportal |
| 14 | PTEN | Ssm | 18 | 494 | 3.6% | cbioportal |
| 15 | RYR2 | Ssm | 18 | 494 | 3.6% | cbioportal |
| 16 | HMCN1 | Ssm | 16 | 494 | 3.2% | cbioportal |
| 17 | OBSCN | Ssm | 16 | 494 | 3.2% | cbioportal |
| 18 | CACNA1E | Ssm | 15 | 494 | 3% | cbioportal |
| 19 | COL11A1 | Ssm | 15 | 494 | 3% | cbioportal |
| 20 | MUC17 | Ssm | 15 | 494 | 3% | cbioportal |
| 21 | RYR1 | Ssm | 15 | 494 | 3% | cbioportal |
| 22 | USH2A | Ssm | 15 | 494 | 3% | cbioportal |
| 23 | MACF1 | Ssm | 14 | 494 | 2.8% | cbioportal |
| 24 | MYO15A | Ssm | 14 | 494 | 2.8% | cbioportal |
| 25 | RP1 | Ssm | 13 | 494 | 2.6% | cbioportal |
| 26 | ZFHX3 | Ssm | 13 | 494 | 2.6% | cbioportal |
| 27 | ABCA13 | Ssm | 12 | 494 | 2.4% | cbioportal |
| 28 | CSMD1 | Ssm | 12 | 494 | 2.4% | cbioportal |
| 29 | DCHS2 | Ssm | 12 | 494 | 2.4% | cbioportal |
| 30 | DNAH17 | Ssm | 12 | 494 | 2.4% | cbioportal |
Data updated 22 days agoSource updated 2026-06-04
99 cases with simple somatic mutation data · 99 cases total · 2026-08-20 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | IDH1 | Ssm | 29 | 99 | 29.3% | cbioportal |
| 2 | TP53 | Ssm | 17 | 99 | 17.2% | cbioportal |
| 4 | SPOP | Ssm | 12 | 99 | 12.1% | cbioportal |
| 3 | FOXA1 | Ssm | 12 | 99 | 12.1% | cbioportal |
| 6 | CTNNB1 | Ssm | 6 | 99 | 6.1% | cbioportal |
| 7 | PIK3CA | Ssm | 6 | 99 | 6.1% | cbioportal |
| 5 | BRCA2 | Ssm | 6 | 99 | 6.1% | cbioportal |
| 9 | KMT2D | Ssm | 5 | 99 | 5.1% | cbioportal |
| 8 | ATM | Ssm | 5 | 99 | 5.1% | cbioportal |
| 12 | IDH2 | Ssm | 4 | 99 | 4% | cbioportal |
| 13 | PTEN | Ssm | 4 | 99 | 4% | cbioportal |
| 10 | APC | Ssm | 4 | 99 | 4% | cbioportal |
| 11 | CDK12 | Ssm | 4 | 99 | 4% | cbioportal |
| 19 | MGA | Ssm | 3 | 96 | 3.1% | cbioportal |
| 22 | ZFHX3 | Ssm | 3 | 96 | 3.1% | cbioportal |
| 18 | KMT2A | Ssm | 3 | 99 | 3% | cbioportal |
| 21 | TSC2 | Ssm | 3 | 99 | 3% | cbioportal |
| 20 | PTPRD | Ssm | 3 | 99 | 3% | cbioportal |
| 16 | JAK1 | Ssm | 3 | 99 | 3% | cbioportal |
| 15 | DNMT3B | Ssm | 3 | 99 | 3% | cbioportal |
| 14 | BCOR | Ssm | 3 | 99 | 3% | cbioportal |
| 17 | KDM6A | Ssm | 3 | 99 | 3% | cbioportal |
| 40 | NSD2 | Ssm | 2 | 89 | 2.2% | cbioportal |
| 117 | LRP1B | Ssm | 1 | 45 | 2.2% | cbioportal |
| 51 | ACVR1B | Ssm | 1 | 45 | 2.2% | cbioportal |
| 119 | MAP3K7 | Ssm | 1 | 45 | 2.2% | cbioportal |
| 93 | FANCL | Ssm | 1 | 45 | 2.2% | cbioportal |
| 124 | MLH3 | Ssm | 1 | 45 | 2.2% | cbioportal |
| 43 | POLD1 | Ssm | 2 | 96 | 2.1% | cbioportal |
| 45 | SMARCA4 | Ssm | 2 | 99 | 2% | cbioportal |
Data updated 22 days agoSource updated 2026-08-20
504 cases with simple somatic mutation data · 504 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 166 | 504 | 32.9% | cbioportal |
| 2 | FOXA1 | Ssm | 58 | 504 | 11.5% | cbioportal |
| 3 | SPOP | Ssm | 47 | 504 | 9.3% | cbioportal |
| 4 | APC | Ssm | 40 | 504 | 7.9% | cbioportal |
| 5 | KMT2C | Ssm | 34 | 504 | 6.7% | cbioportal |
| 6 | PTEN | Ssm | 28 | 504 | 5.6% | cbioportal |
| 7 | CDK12 | Ssm | 27 | 504 | 5.4% | cbioportal |
| 9 | KMT2D | Ssm | 25 | 504 | 5% | cbioportal |
| 8 | AR | Ssm | 25 | 504 | 5% | cbioportal |
| 10 | BRCA2 | Ssm | 24 | 504 | 4.8% | cbioportal |
| 11 | SPEN | Ssm | 21 | 504 | 4.2% | cbioportal |
| 12 | GRIN2A | Ssm | 19 | 504 | 3.8% | cbioportal |
| 13 | ATM | Ssm | 18 | 504 | 3.6% | cbioportal |
| 14 | CTNNB1 | Ssm | 17 | 504 | 3.4% | cbioportal |
| 15 | PIK3CA | Ssm | 17 | 504 | 3.4% | cbioportal |
| 16 | JAK1 | Ssm | 15 | 504 | 3% | cbioportal |
| 27 | MGA | Ssm | 10 | 345 | 2.9% | cbioportal |
| 30 | ZFHX3 | Ssm | 10 | 345 | 2.9% | cbioportal |
| 17 | FAT1 | Ssm | 14 | 504 | 2.8% | cbioportal |
| 18 | RB1 | Ssm | 14 | 504 | 2.8% | cbioportal |
| 20 | MED12 | Ssm | 12 | 504 | 2.4% | cbioportal |
| 21 | NCOR1 | Ssm | 12 | 504 | 2.4% | cbioportal |
| 19 | KMT2A | Ssm | 12 | 504 | 2.4% | cbioportal |
| 23 | KDM6A | Ssm | 11 | 504 | 2.2% | cbioportal |
| 24 | NOTCH1 | Ssm | 11 | 504 | 2.2% | cbioportal |
| 25 | PTPRS | Ssm | 11 | 504 | 2.2% | cbioportal |
| 22 | ASXL1 | Ssm | 11 | 504 | 2.2% | cbioportal |
| 29 | PIK3R1 | Ssm | 10 | 504 | 2% | cbioportal |
| 28 | NSD1 | Ssm | 10 | 504 | 2% | cbioportal |
| 26 | BRAF | Ssm | 10 | 504 | 2% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13
47 cases with simple somatic mutation data · 47 cases total · 2026-01-16 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 32 | 47 | 68.1% | cbioportal |
| 5 | MUC16 | Ssm | 7 | 24 | 29.2% | cbioportal |
| 10 | TTN | Ssm | 6 | 24 | 25% | cbioportal |
| 7 | AEBP1 | Ssm | 6 | 24 | 25% | cbioportal |
| 19 | MACF1 | Ssm | 5 | 24 | 20.8% | cbioportal |
| 18 | LRP1B | Ssm | 5 | 24 | 20.8% | cbioportal |
| 11 | ABHD15 | Ssm | 5 | 24 | 20.8% | cbioportal |
| 14 | CDH23 | Ssm | 5 | 24 | 20.8% | cbioportal |
| 16 | DNAH2 | Ssm | 5 | 24 | 20.8% | cbioportal |
| 17 | HERC1 | Ssm | 5 | 24 | 20.8% | cbioportal |
| 20 | MUC5B | Ssm | 5 | 24 | 20.8% | cbioportal |
| 21 | OBSCN | Ssm | 5 | 24 | 20.8% | cbioportal |
| 26 | TRIOBP | Ssm | 5 | 24 | 20.8% | cbioportal |
| 2 | FOXA1 | Ssm | 8 | 47 | 17% | cbioportal |
| 74 | SYNE3 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 29 | ANK2 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 28 | AHNAK | Ssm | 4 | 24 | 16.7% | cbioportal |
| 71 | SPATA31D1 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 66 | RNF213 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 68 | RYR1 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 69 | RYR2 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 70 | RYR3 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 52 | MUC6 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 75 | TRIM67 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 48 | ITPRID1 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 49 | KCNQ5 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 50 | LAMA3 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 51 | MCF2L2 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 53 | MYO10 | Ssm | 4 | 24 | 16.7% | cbioportal |
| 65 | RAPGEF4 | Ssm | 4 | 24 | 16.7% | cbioportal |
Data updated 22 days agoSource updated 2026-01-16
2,069 cases with simple somatic mutation data · 2,069 cases total · 2026-01-13 · mapped to Prostate Adenocarcinoma EXACT_IDENTIFIER
| # | Gene | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Source |
|---|---|---|---|---|---|---|
| 1 | TP53 | Ssm | 551 | 2,069 | 26.6% | cbioportal |
| 2 | FOXA1 | Ssm | 273 | 2,069 | 13.2% | cbioportal |
| 3 | SPOP | Ssm | 260 | 2,069 | 12.6% | cbioportal |
| 4 | PTEN | Ssm | 155 | 2,069 | 7.5% | cbioportal |
| 5 | KMT2C | Ssm | 140 | 2,069 | 6.8% | cbioportal |
| 6 | APC | Ssm | 138 | 2,069 | 6.7% | cbioportal |
| 7 | KMT2D | Ssm | 133 | 2,069 | 6.4% | cbioportal |
| 9 | ZFHX3 | Ssm | 110 | 1,924 | 5.7% | cbioportal |
| 8 | CDK12 | Ssm | 118 | 2,069 | 5.7% | cbioportal |
| 10 | PIK3CA | Ssm | 92 | 2,069 | 4.4% | cbioportal |
| 11 | ATM | Ssm | 86 | 2,069 | 4.2% | cbioportal |
| 12 | AR | Ssm | 80 | 2,069 | 3.9% | cbioportal |
| 13 | CTNNB1 | Ssm | 78 | 2,069 | 3.8% | cbioportal |
| 14 | BRCA2 | Ssm | 74 | 2,069 | 3.6% | cbioportal |
| 15 | SPEN | Ssm | 70 | 2,069 | 3.4% | cbioportal |
| 27 | ERF | Ssm | 47 | 1,402 | 3.4% | cbioportal |
| 16 | KDM6A | Ssm | 69 | 2,069 | 3.3% | cbioportal |
| 20 | MGA | Ssm | 61 | 1,924 | 3.2% | cbioportal |
| 17 | JAK1 | Ssm | 64 | 2,069 | 3.1% | cbioportal |
| 18 | RB1 | Ssm | 63 | 2,069 | 3% | cbioportal |
| 19 | GRIN2A | Ssm | 61 | 2,069 | 2.9% | cbioportal |
| 21 | FAT1 | Ssm | 56 | 2,069 | 2.7% | cbioportal |
| 23 | MED12 | Ssm | 52 | 2,069 | 2.5% | cbioportal |
| 22 | KMT2A | Ssm | 52 | 2,069 | 2.5% | cbioportal |
| 25 | NCOR1 | Ssm | 50 | 2,069 | 2.4% | cbioportal |
| 24 | ASXL1 | Ssm | 50 | 2,069 | 2.4% | cbioportal |
| 26 | PTPRD | Ssm | 49 | 2,069 | 2.4% | cbioportal |
| 44 | KMT2B | Ssm | 32 | 1,402 | 2.3% | cbioportal |
| 28 | ARID1A | Ssm | 43 | 2,069 | 2.1% | cbioportal |
| 29 | PIK3R1 | Ssm | 41 | 2,069 | 2% | cbioportal |
Data updated 22 days agoSource updated 2026-01-13